Status:
COMPLETED
Varenicline Versus Cytisine for Smoking Cessation in Primary Care Setting
Lead Sponsor:
University of Zagreb
Collaborating Sponsors:
University of Ljubljana School of Medicine, Slovenia
University of Zagreb School of Medicine
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The overall goals of this study are to 1) assess awareness of interest in the use of pharmacotherapy for smoking cessation in Croatia and Slovenia, countries in Central Europe with very high smoking p...
Eligibility Criteria
Inclusion
- Receive care in one of forty family medicine practices in Croatia and Slovenia
- Aged 18 or older
- Current smokers
- Indicate a desire to stop smoking and to use pharmacotherapy.
Exclusion
- Mental illness who cannot provide informed consent for the study
- Pregnant or breastfeeding.
Key Trial Info
Start Date :
July 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
352 Patients enrolled
Trial Details
Trial ID
NCT04015414
Start Date
July 14 2020
End Date
November 1 2022
Last Update
November 3 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Zagreb School of Medicine
Zagreb, Croatia, 10000
2
University of Ljubljana School of Medicine
Ljubljana, Slovenia, 1000